Hamizi, S., Freyer, G., Bakrin, N., Henin, E., Mohtaram, A., Le Saux, O., & Falandry, C. (2013). Subcutaneous trastuzumab: Development of a new formulation for treatment of HER2-positive early breast cancer. Dove Medical Press.

Hamizi, Salima, Gilles Freyer, Naoual Bakrin, Emilie Henin, Amina Mohtaram, Olivia Le Saux, و Claire Falandry. Subcutaneous Trastuzumab: Development of a New Formulation for Treatment of HER2-positive Early Breast Cancer. Dove Medical Press, 2013.

Hamizi, Salima, et al. Subcutaneous Trastuzumab: Development of a New Formulation for Treatment of HER2-positive Early Breast Cancer. Dove Medical Press, 2013.